Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.

Jack CR Jr, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Waring SC, Tangalos EG, Kokmen E.

Neurology. 1999 Apr 22;52(7):1397-403.

2.

Rates of hippocampal atrophy correlate with change in clinical status in aging and AD.

Jack CR Jr, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Tangalos EG, Kokmen E.

Neurology. 2000 Aug 22;55(4):484-89.

3.

Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.

Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, Rusinek H, Pelton GH, Honig LS, Mayeux R, Stern Y, Tabert MH, de Leon MJ.

Neurology. 2007 Mar 13;68(11):828-36.

PMID:
17353470
4.

Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.

Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM.

Arch Neurol. 2006 May;63(5):693-9. Erratum in: Arch Neurol. 2007 Sep;64(9):1360-1.

PMID:
16682538
5.

Prediction of Alzheimer's disease in mild cognitive impairment: a prospective study in Taiwan.

Wang PN, Lirng JF, Lin KN, Chang FC, Liu HC.

Neurobiol Aging. 2006 Dec;27(12):1797-806.

PMID:
16321457
6.

Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.

Jack CR Jr, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Cha RH, Tangalos EG, Petersen RC.

Neurology. 2004 Feb 24;62(4):591-600.

7.

MRI and CSF studies in the early diagnosis of Alzheimer's disease.

de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Clark C, Kerkman D, DeBernardis J, Li J, Lair L, Reisberg B, Tsui W, Rusinek H.

J Intern Med. 2004 Sep;256(3):205-23.

8.

Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.

Wang PN, Liu HC, Lirng JF, Lin KN, Wu ZA.

Psychiatry Res. 2009 Mar 31;171(3):221-31. doi: 10.1016/j.pscychresns.2008.05.002. Epub 2009 Feb 13.

PMID:
19217759
9.

Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial.

Grundman M, Sencakova D, Jack CR Jr, Petersen RC, Kim HT, Schultz A, Weiner MF, DeCarli C, DeKosky ST, van Dyck C, Thomas RG, Thal LJ; Alzheimer's Disease Cooperative Study.

J Mol Neurosci. 2002 Aug-Oct;19(1-2):23-7.

PMID:
12212787
10.

Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI.

Jack CR Jr, Shiung MM, Weigand SD, O'Brien PC, Gunter JL, Boeve BF, Knopman DS, Smith GE, Ivnik RJ, Tangalos EG, Petersen RC.

Neurology. 2005 Oct 25;65(8):1227-31.

11.

Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.

Fleisher AS, Sun S, Taylor C, Ward CP, Gamst AC, Petersen RC, Jack CR Jr, Aisen PS, Thal LJ.

Neurology. 2008 Jan 15;70(3):191-9. doi: 10.1212/01.wnl.0000287091.57376.65.

PMID:
18195264
12.

Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.

Risacher SL, Saykin AJ, West JD, Shen L, Firpi HA, McDonald BC; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Curr Alzheimer Res. 2009 Aug;6(4):347-61.

13.

Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.

Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Hua X, Toga AW, Jack CR Jr, Schuff N, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2009 Sep;30(9):2766-88. doi: 10.1002/hbm.20708.

14.

Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.

Henneman WJ, Sluimer JD, Barnes J, van der Flier WM, Sluimer IC, Fox NC, Scheltens P, Vrenken H, Barkhof F.

Neurology. 2009 Mar 17;72(11):999-1007. doi: 10.1212/01.wnl.0000344568.09360.31.

15.

Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.

Brueggen K, Dyrba M, Barkhof F, Hausner L, Filippi M, Nestor PJ, Hauenstein K, Klöppel S, Grothe MJ, Kasper E, Teipel SJ.

J Alzheimers Dis. 2015;48(1):197-204. doi: 10.3233/JAD-150063.

PMID:
26401940
16.

MRI of hippocampus and entorhinal cortex in mild cognitive impairment: a follow-up study.

Tapiola T, Pennanen C, Tapiola M, Tervo S, Kivipelto M, Hänninen T, Pihlajamäki M, Laakso MP, Hallikainen M, Hämäläinen A, Vanhanen M, Helkala EL, Vanninen R, Nissinen A, Rossi R, Frisoni GB, Soininen H.

Neurobiol Aging. 2008 Jan;29(1):31-8. Epub 2006 Nov 13.

PMID:
17097769
17.

White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.

Lindemer ER, Salat DH, Smith EE, Nguyen K, Fischl B, Greve DN; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2015 Sep;36(9):2447-57. doi: 10.1016/j.neurobiolaging.2015.05.011. Epub 2015 May 28.

18.

Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment.

van de Pol LA, van der Flier WM, Korf ES, Fox NC, Barkhof F, Scheltens P.

Neurology. 2007 Oct 9;69(15):1491-7.

PMID:
17923611
19.

Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: Meta-analyses of MRI studies.

Shi F, Liu B, Zhou Y, Yu C, Jiang T.

Hippocampus. 2009 Nov;19(11):1055-64. doi: 10.1002/hipo.20573.

PMID:
19309039
20.

The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia.

Luckhaus C, Cohnen M, Flüss MO, Jänner M, Grass-Kapanke B, Teipel SJ, Grothe M, Hampel H, Peters O, Kornhuber J, Maier W, Supprian T, Gaebel W, Mödder U, Wittsack HJ.

Psychiatry Res. 2010 Jul 30;183(1):44-51. doi: 10.1016/j.pscychresns.2010.04.003. Epub 2010 Jun 11.

PMID:
20541374

Supplemental Content

Support Center